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Abstract
Stem cells are a promising tool for treatment of a variety of degenerative diseases. Human amniotic epithelial stem cells (hAECs)
have desirable and unique characteristics that make them a proper candidate for cell therapy. In this study, we have investigated
the effects of BMP-4 (bone morphogenetic protein-4) and its inhibition on differentiation of AECs into ectodermal lineages.
Analysis of AEC-derived ectodermal lineages (neurons and keratinocytes) was performed by using flow cytometry technique for
Map2 and β-tubulin (as neuron markers), Olig2 and MBP (as oligodendrocyte markers), and K14 and K10 (as keratinocyte
markers). The results of this study illustrated that noggin (as BMP antagonist), BMP4, and both BMP4 and heparin (together or
separately) increased neural and keratinocyte marker expression, respectively. The expression of markers MAP2, olig2, and K14
in hAECs has been significantly decreased 21 days after exposure to differentiation medium (without growth factors) compared
with isolation day, which supports the hypothesis that AECs can be dedifferentiated into pluripotent cells. Moreover, activation
and inhibition of BMP signaling have no effects on viability of hAECs. The results of this study showed that BMP signaling and
its inhibition are the key factors for ectodermal lineage differentiation of amnion-derived stem cells.
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Introduction
Recently, cell therapy holds a great promise for the treatment of
various diseases such as neurodegenerative diseases (e.g., spi-
nal cord injury, multiple sclerosis, and Parkinson disease) and
wound healing. Using proper cell source for this purpose is very
important. Human amniotic epithelial cells (hAECs), which are
isolated from human placenta, have favorable and unique char-
acteristics that make them highlighted and attractive for cell
therapy. Remarkable properties of hAECs are low immunoge-
nicity, non-tumorigenicity, secretion of several growth factors
such as epithelial growth factor (EGF), keratinocyte growth
factor (KGF), transforming growth factors (TGFβ) (Niknejad
et al. 2008; Si et al. 2015; Zhang et al. 2017), as well as immu-
nomodulatory and anti-inflammatory features. Moreover, these
cells can be achieved in extensive amounts without ethical con-
cerns in comparison with the other fetal stem cells (Liu et al.
2012). Furthermore, AECs express stem cell surface markers
and the pluripotency transcription factors such as octamer-
binding protein 4 (Oct-4), Nanog, Lefty A, sex determining
region Y-box 2 (SOX-2), and teratocarcinoma-derived growth
factor 1 (TDGF1) (Maymó et al. 2018). hAECs are able to
differentiate to all three germ layers of endodermal (pancreatic
and hepatic cells), mesodermal (cardiac cells), and ectodermal
(nervous system and skin) lineages (Wang et al. 2018).
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